Neuronal mdr-1 gene expression after experimental focal hypoxia: A new obstacle for neuroprotection?

Journal of the Neurological Sciences

Volumn 258, Issue 1-2, 2007, Pages 84-92

  Lazarowski, Alberto ^a   Caltana, Laura ^a   Merelli, Amalia ^a   Rubio, Maria Dolores ^a   Ramos, Alberto Javier ^a   Brusco, Alicia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Astrocytes; Cobalt chloride; Hypoxia; MDR 1; Multidrug resistance; Neurons; Neuroprotection; P gp

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN P; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 1; PHOSGENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BRAIN HYPOXIA; BRAIN NERVE CELL; CAPILLARY FLOW; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; EXPERIMENTAL STUDY; FRONTAL CORTEX; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTION; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY;

ANIMALS; ANOXIA; ANTIMUTAGENIC AGENTS; COBALT; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; P-GLYCOPROTEIN; PARIETAL LOBE; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, WISTAR;

EID: 34249937062     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.03.004     Document Type: Article

References (50)

1. Leker R., and Shohami E. Cerebral ischemia and trauma - different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev 39 (2002) 55-73
2. Lyden P.D., Lees K.R., and Davis S.M. Alteplase for acute stroke revisited: the first 10 years. Lancet Neurol 5 (2006) 722-724
3. Kochanek P., Clark R., Ruppel R., Adelson P., Bell M., Whalen M., et al. Biochemical, cellular and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: lessons learned from the bedside. Pediatr Crit Care 1 (2000) 4-19
4. Krajewski S., Krajewska M., Ellerby L.M., Welsh K., Xie Z., Deveraux Q.L., et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci U S A 96 (1999) 5752-5757
5. The National Institute of Neurological Disorders and Stroke (NINDS), and rt-PA Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke: experience at eight centers and implications for community practice and patient care. Stroke 28 (1997) 1530-1540
6. Brott T., and Bogousslavsky J. Treatment of acute ischemic stroke. N Engl J Med 343 (2000) 710-722
7. Adams Jr. H.P., Adams R.J., Brott T., del Zoppo G.J., Furlan A., Goldstein L.B., et al. Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34 (2003) 1056-1083
8. Kidwell C.S., Saver J.L., Mattiello J., Starkman S., Vinuela F., Duckwiler G., et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 47 (2000) 462-469
9. Lee G., Dallas S., Hong M., and Bendayan R. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev 53 (2001) 569-596
10. Hong M., Schlichter L., and Bendayan R. A novel zidovudine uptake system in microglia. J Pharmacol Exp Ther 296 (2001) 141-149
11. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2 (2002) 48-58
12. Cordon Cardo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., and Melamed M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38 (1990) 1277-1287
13. Ramos A.J., Lazarowski A., Villar M.J., and Brusco A. Transient Expression of MDR-1/P-Glycoprotein in a Model of Partial Cortical Devascularization. Cell Mol Neurobiol 24 (2004) 101-107
14. Lazarowski A., Ramos A.J., García-Rivello H., Brusco A., and Girardi E. Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model. Cell Mol Neurobiol 24 (2004) 77-85
15. Lazarowski A., Massaro M., Schteinschnaider A., Intruvini S., Sevlever G., and Rabinowicz A. Neuronal MDR-1 gene expression and persistent low levels of anticonvulsants in a child with refractory epilepsy. Ther Drug Monit 26 (2004) 44-46
16. Ji Z., Yang G., Shahzidi S., Tkacz-Stachowska K., Suo Z., Nesland J.M., et al. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett 244 (2006) 182-189
17. Tanaka T., Kojima I., Ohse T., Ingelfinger J.R., Adler S., Fujita T., et al. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest 85 (2005) 1292-1307
18. Semenza G.L. Physiology meets biophysics: visualizing the interaction of hypoxia-inducible factor 1a with p300 and CBP. PNAS 99 (2002) 11570-11572
19. Comerford K.M., Wallace T.J., Karhausen J., Louis N.A., Montalto M.C., and Colgan S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62 (2002) 3387-3394
20. Wang G.L., and Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268 (1993) 21513-21518
21. Wang G.L., and Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90 (1993) 4304-4308
22. Roessner C.A., Santander P.J., and Scott A.I. Multiple biosynthetic pathways for vitamin B12: variations on a central theme. Vitam Horm 61 (2001) 267-297
23. Hara A., Niwa M., Aoki H., Kumada M., Kunisada T., Oyama T., et al. A new model of retinal photoreceptor cell degeneration induced by a chemical hypoxia-mimicking agent, cobalt chloride. Brain Res 1109 (2006) 192-200
24. Caltana L.R., Lazarowski A., Ramos A.J., and Brusco H.A. Intracerebral cobalt chloride injection: a new model of focal hypoxic injury? Program No. 407.6. 2005 Abstract Viewer/Itinerary Planner (2005), Society for Neuroscience, Washington, DC Online
25. Yuan Y., Hilliard G., Ferguson T., and Millhorn D.E. Cobalt Inhibits the Interaction between hypoxia-inducible factor-a and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-a. J Biol Chem 278 (2003) 15911-15916
26. Ramos A.J., Evrard S.G., Tagliaferro P., Tricarico M.V., and Brusco A. Effects of chronic maternal ethanol exposure on hippocampal and striatal morphology in offspring. Ann NY Acad Sci 965 (2002) 343-353
27. Gibson C.L., Coughlan T.C., and Murphy S.P. Glial nitric oxide and ischemia. Glia 50 (2005) 417-426
28. Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17 (1963) 208-212
29. Semenza G.L. Surviving ischemia: adaptive responses mediated byhypoxiainducible factor 1. J Clin Invest 106 (2000) 809-812
30. Vengellur A., and LaPres J. The role of hypoxia inducible factor 1 alpha in cobalt chloride induced cell death in mouse embryonic fibroblasts. Toxicol Sci 82 (2004) 638-646
31. Yang S.J., Pyen J., Lee I., Lee H., Kim Y., and Kim T. Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells. J Biochem Mol Biol 31 37 (2004) 480-486
32. Araya J., Maruyama M., Inoue A., Fujita T., Kawahara J., Sassa K., et al. Inhibition of proteasome activity is involved in cobalt-induced apoptosis of human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 283 (2002) L849-L858
33. Zou W., Zeng J., Zhuo M., Xu W., Sun L., Wang J., et al. Involvement of caspase-3 and p38 mitogen-activated protein kinase in cobalt chloride-induced apoptosis in PC12 cells. J Neurosci Res 67 (2002) 837-843
34. Kim H.J., Yang S.J., Kim Y.S., and Kim T.U. Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase activation in human cervical cancer HeLa cells. J Biochem Mol Biol 36 (2003) 468-474
35. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
36. Loscher W., and Potschka H. Blood-brain barrier active efflux transporters: ATPbinding cassette gene family. NeuroRx 2 (2005) 86-98
37. Kwan P., and Brodie M. Potential role of drug transporters in pathogenesis of medically intractable epilepsy. Epilepsia 46 2 (2005) 224-235
38. Remy S., and Beck H. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129 (2006) 18-35
39. Lazarowski A., Czornyj L., Lubieniecki F., Vazquez S., D'Giano C., Sevlever G., et al. Multidrug-resistance (MDR) proteins develops refractory epilepsy phenotype: clinical and experimental evidences. Curr Drug Ther 1 3 (2006) 291-309
40. Spudich A., Kilic E., Xing H., Kilic U., Rentsch K.M., Wunderli-Allenspach H., et al. Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 9 (2006) 487-488
41. Del Zoppo G.J. Stroke and neurovascular protection. N Engl J Med 354 (2006) 553-555
42. Hôcht C, Lazarowski A, Gonzalez NN, Auzmendib J, Opezzo JAW, Bramuglia GF, Taira CA, Girardi E. Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model. Neurosci Lett 413 (2007) 168-172.
43. Chengyun D., Guoming L., Elia M., Catania M.V., and Qunyuan X. Expression of multidrug resistance type 1 gene (MDR1) P-glycoprotein in intractable epilepsy with different aetiologies: a double-labelling and electron microscopy study. Neurol Sci 27 (2006) 245-251
44. Robinsdon L.J., Roberts W.K., Ling T.T., Lamming D., Sternberg S.S., and Roepe P.D. Human MDR1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 36 (1997) 11169-11178
45. Johnstone R.W., Cretney E., and Smyth A. P-glycoprotein protects leukemia cells agonist caspase-dependent but not caspase-independent cell death. Blood 93 (1999) 1075-1085
46. Shtil A.A., and Azare J. Redundancy of biological regulation as the basis of emergence of multidrug resistance. Int Rev Cytol 246 (2005) 1-29
47. Begley D.J. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 104 (2004) 29-45
48. Lazarowski A.J., Garcia Rivello H.J., Vera Janavel G.L., Cuniberti L.A., Cabeza Meckert P.M., Yannarelli G.G., et al. Cardiomyocytes of chronically ischemic pig hearts express the MDR-1 gene-encoded P-glycoprotein. J Histochem Cytochem 53 (2005) 845-850
49. Laguens R.P., Lazarowski A.J., Cuniberti L.A., Janavel G.L., Meckert P.M., Yannarelli G.G., et al. Expression of the MDR-1 gene-encoded P-glycoprotein in cardiomyocytes of conscious sheep undergoing acute myocardial ischemia followed by reperfusion. J Histochem Cytochem 55 (2007) 191-197 [Epub 2006 Nov 13.]
50. Lin T., Islam O., and Heese K. ABC transporters, neural stem cells and neurogenesis - a different perspective. Cell Res (2006) 1-15